Rust et al v. Johnson & Johnson et al
Nancy Rust and B. C. C. |
Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco, McKinsey & Company, Inc. United States and West Virginia Board of Pharmacy |
5:2021cv00449 |
August 11, 2021 |
US District Court for the Southern District of West Virginia |
Frank W Volk |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on August 23, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
![]() |
Filing 9 STIPULATION EXTENDING TIME for West Virginia Board of Pharmacy to respond to Complaint by West Virginia Board of Pharmacy, Nancy Rust, B. C. C. (Taylor, Justin) (Modified on 8/19/2021 to add party filers) (mk). |
Filing 8 STIPULATION EXTENDING TIME for Johnson & Johnson and Janssen Pharmaceuticals, Inc. to respond to Complaint by Johnson & Johnson, Janssen Pharmaceuticals, Inc., Nancy Rust, B. C. C. (Williams, Marc) (Modified on 8/17/2021 to add party filers) (mk). |
Filing 7 JOINT MOTION by Johnson & Johnson, McKinsey & Company, Inc. United States, Janssen Pharmaceuticals, Inc. for an Immediate Stay of All Further Proceedings and Deadlines Pending Transfer of this Action to Multi District Litigation re: #1 Notice of Removal (Attachment: #1 Exhibit 1)(George, Keith) (Modified on 8/16/2021 to add party filer) (mk). |
Filing 6 STIPULATION EXTENDING TIME IN WHICH MCKINSEY MAY RESPOND TO COMPLAINT by Nancy Rust, B.C.C., McKinsey & Company, Inc. United States; said parties stipulate that the time within which McKinsey may move, answer or defend in any manner to the Complaint is extended to and including thirty (30) days after the later of (i) this Courts decision on any remand motion or (ii) the date that the Judicial Panel on Multidistrict Litigation ("JPML") sustains any valid objection to transfer of the claims against McKinsey in this Action to In re: McKinsey & Company, Inc. National Prescription Opiate Consultant Litigation, MDL No. 2996, pending in the United States District Court for the Northern District of California (the "McKinsey MDL"). (George, Keith) (Modified on 8/13/2021 to add party filers) |
Filing 5 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant McKinsey & Company, Inc. United States (George, Keith) |
Filing 4 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendants Janssen Pharmaceuticals, Inc., Johnson & Johnson (Williams, Marc) |
Filing 3 AMENDED CERTIFICATE OF SERVICE by Janssen Pharmaceuticals, Inc., Johnson & Johnson for Notice of Removal. (Williams, Marc) |
Filing 2 STANDING ORDER IN RE: ASSIGNMENT AND REFERRAL OF CIVIL ACTIONS AND MATTERS TO MAGISTRATE JUDGES ENTERED JANUARY 4, 2016. Discovery referred to Magistrate Judge Aboulhosn. (cc: counsel of record; any unrepresented party) (btm) |
Filing 1 NOTICE OF REMOVAL by Johnson & Johnson, Janssen Pharmaceuticals, Inc., McKinsey & Company, Inc. United States with complaint and docket sheet from Circuit Court of Greenbrier County. Filing Fee $402.00. Receipt #AWVSDC-8008893. (Attachments: #1 State Court Complaint, #2 State Court Docket Sheet, #3 Civil Cover Sheet) (btm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.